These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22297068)

  • 1. Differential association between the norepinephrine transporter gene and ADHD: role of sex and subtype.
    Sengupta SM; Grizenko N; Thakur GA; Bellingham J; DeGuzman R; Robinson S; TerStepanian M; Poloskia A; Shaheen SM; Fortier ME; Choudhry Z; Joober R
    J Psychiatry Neurosci; 2012 Feb; 37(2):129-37. PubMed ID: 22297068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association analysis of norepinephrine transporter polymorphisms and methylphenidate response in ADHD patients.
    Angyal N; Horvath EZ; Tarnok Z; Richman MJ; Bognar E; Lakatos K; Sasvari-Szekely M; Nemoda Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):122-128. PubMed ID: 29374517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A haplotype of the norepinephrine transporter gene (SLC6A2) is associated with visual memory in attention-deficit/hyperactivity disorder.
    Shang CY; Chiang HL; Gau SS
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Apr; 58():89-96. PubMed ID: 25554436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive phenotype/genotype analyses of the norepinephrine transporter gene (SLC6A2) in ADHD: relation to maternal smoking during pregnancy.
    Thakur GA; Sengupta SM; Grizenko N; Choudhry Z; Joober R
    PLoS One; 2012; 7(11):e49616. PubMed ID: 23185385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No evidence for association between a functional promoter variant of the Norepinephrine Transporter gene SLC6A2 and ADHD in a family-based sample.
    Renner TJ; Nguyen TT; Romanos M; Walitza S; Röser C; Reif A; Schäfer H; Warnke A; Gerlach M; Lesch KP
    Atten Defic Hyperact Disord; 2011 Sep; 3(3):285-9. PubMed ID: 21739117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A haplotype of the norepinephrine transporter (Net) gene Slc6a2 is associated with clinical response to atomoxetine in attention-deficit hyperactivity disorder (ADHD).
    Ramoz N; Boni C; Downing AM; Close SL; Peters SL; Prokop AM; Allen AJ; Hamon M; Purper-Ouakil D; Gorwood P
    Neuropsychopharmacology; 2009 Aug; 34(9):2135-42. PubMed ID: 19387424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replication of a rare protective allele in the noradrenaline transporter gene and ADHD.
    Xu X; Hawi Z; Brookes KJ; Anney R; Bellgrove M; Franke B; Barry E; Chen W; Kuntsi J; Banaschewski T; Buitelaar J; Ebstein R; Fitzgerald M; Miranda A; Oades RD; Roeyers H; Rothenberger A; Sergeant J; Sonuga-Barke E; Steinhausen HC; Faraone SV; Gill M; Asherson P
    Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1564-7. PubMed ID: 18937296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of norepinephrine transporter (NET, SLC6A2) genotype with ADHD-related phenotypes: findings of a longitudinal study from birth to adolescence.
    Hohmann S; Hohm E; Treutlein J; Blomeyer D; Jennen-Steinmetz C; Schmidt MH; Esser G; Banaschewski T; Brandeis D; Laucht M
    Psychiatry Res; 2015 Apr; 226(2-3):425-33. PubMed ID: 25724484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No evidence of an association between norepinephrine transporter gene polymorphisms and attention deficit hyperactivity disorder: a family-based and case-control association study in a Korean sample.
    Cho SC; Kim JW; Kim BN; Hwang JW; Park M; Kim SA; Cho DY; Yoo HJ; Chung US; Son JW; Park TW
    Neuropsychobiology; 2008; 57(3):131-8. PubMed ID: 18552510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norepinephrine transporter and catecholamine-O-methyltransferase gene variants and attention-deficit/hyperactivity disorder symptoms in adults.
    Retz W; Rösler M; Kissling C; Wiemann S; Hünnerkopf R; Coogan A; Thome J; Freitag C
    J Neural Transm (Vienna); 2008; 115(2):323-9. PubMed ID: 17994190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The possible involvement of genetic variants of NET1 in the etiology of attention-deficit/hyperactivity disorder comorbid with oppositional defiant disorder.
    Liu L; Cheng J; Li H; Yang L; Qian Q; Wang Y
    J Child Psychol Psychiatry; 2015 Jan; 56(1):58-66. PubMed ID: 24942521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association studies of -3081(A/T) polymorphism of norepinephrine transporter gene with attention deficit/hyperactivity disorder in Korean population.
    Joung Y; Kim CH; Moon J; Jang WS; Yang J; Shin D; Lee S; Kim KS
    Am J Med Genet B Neuropsychiatr Genet; 2010 Mar; 153B(2):691-694. PubMed ID: 19685476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the 5HT1B receptor gene (HTR1B) and the inattentive subtype of ADHD.
    Smoller JW; Biederman J; Arbeitman L; Doyle AE; Fagerness J; Perlis RH; Sklar P; Faraone SV
    Biol Psychiatry; 2006 Mar; 59(5):460-7. PubMed ID: 16197923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further evidence of association between two NET single-nucleotide polymorphisms with ADHD.
    Kim JW; Biederman J; McGrath CL; Doyle AE; Mick E; Fagerness J; Purcell S; Smoller JW; Sklar P; Faraone SV
    Mol Psychiatry; 2008 Jun; 13(6):624-30. PubMed ID: 17876324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible effect of norepinephrine transporter polymorphisms on methylphenidate-induced changes in neuropsychological function in attention-deficit hyperactivity disorder.
    Park S; Kim JW; Yang YH; Hong SB; Park MH; Kim BN; Shin MS; Yoo HJ; Cho SC
    Behav Brain Funct; 2012 May; 8():22. PubMed ID: 22591463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PET.
    Sigurdardottir HL; Kranz GS; Rami-Mark C; James GM; Vanicek T; Gryglewski G; Kautzky A; Hienert M; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Rujescu D; Kasper S; Lanzenberger R
    Hum Brain Mapp; 2016 Mar; 37(3):884-95. PubMed ID: 26678348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible association of norepinephrine transporter -3081(A/T) polymorphism with methylphenidate response in attention deficit hyperactivity disorder.
    Kim BN; Kim JW; Hong SB; Cho SC; Shin MS; Yoo HJ
    Behav Brain Funct; 2010 Oct; 6():57. PubMed ID: 20929549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing for the mediating role of endophenotypes using molecular genetic data in a twin study of ADHD traits.
    Pinto R; Asherson P; Ilott N; Cheung CH; Kuntsi J
    Am J Med Genet B Neuropsychiatr Genet; 2016 Oct; 171(7):982-92. PubMed ID: 27230021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional gene variation in the human norepinephrine transporter: association with attention deficit hyperactivity disorder.
    Kim CH; Waldman ID; Blakely RD; Kim KS
    Ann N Y Acad Sci; 2008; 1129():256-60. PubMed ID: 18591486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A common haplotype at the dopamine transporter gene 5' region is associated with attention-deficit/hyperactivity disorder.
    Genro JP; Polanczyk GV; Zeni C; Oliveira AS; Roman T; Rohde LA; Hutz MH
    Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1568-75. PubMed ID: 18802919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.